Results 31 to 40 of about 1,819,904 (233)

Outcomes of supraflex Sirolimus-eluting coronary stents

open access: yesCurrent Medical Issues, 2022
Background: The development of a sirolimus-eluting coronary stent (SES) was a big step forward in interventional cardiology. SES has been demonstrated in large, randomized clinical studies to reduce angiographic restenosis and target vessel ...
Vishal Virendra Singh   +2 more
doaj   +1 more source

Drug-eluting stent in diabetes [PDF]

open access: yesSao Paulo Medical Journal, 2007
Long-term evaluation of cardiovascular risk among diabetic patients has shown that the incidence of death due to myocardial infarction among these patients is 20%, whereas among nondiabetic patients it is only 3.5%. Such observations haveled to classifying diabetes as a risk that is equivalent to establi shed coronary artery disease.
Lemos Júnior, Hernani Pinto de   +2 more
openaire   +4 more sources

Randomized Comparison of Sirolimus and Paclitaxel Drug-Eluting Stents for Long Lesions in the Left Anterior Descending Artery: an Intravascular Ultrasound Study [PDF]

open access: yes, 2008
The objective of this prospective randomized study was to verify whether the superiority of the sirolimus-eluting stent (SES) in inhibiting neointimal hyperplasia could be demonstrated in complex coronary lesions. The SES was compared with the paclitaxel-
BRANCHITTA, GIULIA
core   +1 more source

Biodegradable Cable-Tie Rapamycin-eluting Stents

open access: yesScientific Reports, 2017
“Cable-tie” type biodegradable stents with drug-eluting nanofiber were developed to treat rabbit denuded arteries in this study. Biodegradable stents were fabricated using poly-L-lactide film following being cut and rolled into a cable-tie type stent ...
Cheng-Hung Lee   +11 more
doaj   +1 more source

Examination of the coatings of coronary stents [PDF]

open access: yes, 2006
In our study the main properties of coated coronary stents are shown, such as foreshortening, recoil, surface features and failures and the expansion properties. The types and the effects of active and passive coatings are introduced.
Dobránszky, János   +3 more
core   +1 more source

Reestenose tardia associada à fratura de stent Cypher Reestenosis tardía asociada a fractura de stent Cypher Late restenosis related to Cypher stent fracture

open access: yesArquivos Brasileiros de Cardiologia, 2009
Os stents farmacológicos representam um importante avanço na terapêutica da doença aterosclerótica coronariana. Recentemente tem sido descrita a fratura de stents farmacológicos, associada à reestenose e trombose.
Michel Pereira Cadore   +3 more
doaj   +1 more source

Comparative efficacy of drug-eluting balloon and drug-eluting stent for treatment of in-stent restenosis: a systematic review and meta-analysis

open access: yesJournal of the Pakistan Medical Association
Objective: To compare the efficacy of drug-eluting stents and drug-eluting balloons in treating in-stent restenosis. Method: The systematic review was conducted from January to February 2022, and comprised literature search on PubMed, ProQuest ...
Tinanda Tarigan   +3 more
doaj   +1 more source

The stenting strategy of drug-eluting stents for coronary artery disease in patients on dialysis

open access: yesSAGE Open Medicine, 2014
Background: Reports regarding the relationship between the length and diameter of implanted drug-eluting stents and clinical and angiographic outcomes in dialysis patients are limited.
Hiroshi Fujita   +6 more
doaj   +1 more source

Does the use of paclitaxel or rapamycin-eluting stent decrease further need for coronary-artery bypass grafting when compared with bare-metal stent?

open access: yesSão Paulo Medical Journal
CONTEXT AND OBJECTIVE: The safety and efficacy of drug-eluting stents reduce the need for surgical revascularization. The objective of the present study was to investigate whether paclitaxel or rapamycin-eluting stent are effective in avoiding the need ...
Hernani Pinto de Lemos Júnior   +1 more
doaj   +1 more source

An Integrated Oxygen‐Supplying Device and Predictive Multiphysics Model for Extended Ambient Transport of Insulin‐Producing Cells

open access: yesAdvanced Functional Materials, EarlyView.
Cell therapies typically rely on cold‐chain logistics and cryopreservation, limiting access and compromising cell quality. Here, a dual‐chamber device separates an oxygen‐supplying chamber from a hyaluronic acid cargo chamber, sustaining oxygen delivery for over 70 h and enabling ambient‐temperature shipment.
Daniel A. Domingo‐Lopez   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy